Cleared Traditional

K870453 - DS-DNA EIA DIAGNOSTIC KIT

K870453 is an FDA 510(k) clearance for DS-DNA EIA DIAGNOSTIC KIT, manufactured by Biohytech International, Inc.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 62-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
62d
Days
Class 2
Risk

K870453 is an FDA 510(k) clearance for the DS-DNA EIA DIAGNOSTIC KIT. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by Biohytech International, Inc. (Chicago, US). The FDA issued a Cleared decision on March 24, 1987 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K870453

510(k) Number K870453 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 1987
Decision Date March 24, 1987
Days to Decision 62 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 105d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 111
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K870453.
LA ANTIBODY TEST KIT
K874195 · Lipogen, Inc. · Mar 1988
LIPOGEN ANA TEST KIT
K875246 · Lipogen, Inc. · Feb 1988
ANTINUCLEAR ANTIBODY TEST
K872839 · Cappel Diagnostics, Inc. · Oct 1987
SS-DNA EIA DIAGNOSTIC KIT
K870452 · Biohytech International, Inc. · Mar 1987
SM EIA DIAGNOSTIC KIT
K870455 · Biohytech International, Inc. · Mar 1987
DNP EIA DIAGNOSTIC KIT
K870456 · Biohytech International, Inc. · Mar 1987